EDGAR Filing Documents for 0001193125-17-162694

Form 8-K - Current report:

SEC Accession No. 0001193125-17-162694

Filing Date

2017-05-08

Accepted

2017-05-08 16:40:04

Documents

Period of Report

2017-05-03

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d393964d8k.htm	8-K	23357
2	EX-3.1	d393964dex31.htm	EX-3.1	101081
3	EX-3.2	d393964dex32.htm	EX-3.2	114329
	Complete submission text file	0001193125-17-162694.txt		240118

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024

Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500

PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)